-
twitter @ ssrn- NYT reports on China's WTO problems: http://ping.fm/tJ7aK But, green economy is raising trade issues in US too: http://ping.fm/Q2g5D September 10, 2010NYT reports on China's WTO problems: http://ping.fm/tJ7aK But, green economy is raising trade issues in US too: http://ping.fm/Q2g5D […]jwalshy_307 (Joe Walsh)
- SSRN has turned into the Twitterverse for finance papers - this makes money but im not going to tell you how to reproduce my study #fail September 10, 2010SSRN has turned into the Twitterverse for finance papers - this makes money but im not going to tell you how to reproduce my study #fail […]ZipperTheory (Zipper Theory)
- “@wharton: RT @faderp: New paper: "Identifying the Aggregation Bias in Sponsored Search Data" http://bit.ly/cKqRwl @WhartonInteract” September 10, 2010“@wharton: RT @faderp: New paper: "Identifying the Aggregation Bias in Sponsored Search Data" http://bit.ly/cKqRwl @WhartonInteract” […]matthewbdf (Matthew Delle Fave)
- RT @faderp: New paper: "Identifying the Aggregation Bias in Sponsored Search Data" http://bit.ly/cKqRwl @WhartonInteract #fb September 10, 2010RT @faderp: New paper: "Identifying the Aggregation Bias in Sponsored Search Data" http://bit.ly/cKqRwl @WhartonInteract #fb […]WhartonInteract (Wharton Interactive)
- RT @faderp: New paper: "Identifying the Aggregation Bias in Sponsored Search Data" http://bit.ly/cKqRwl @WhartonInteract September 10, 2010RT @faderp: New paper: "Identifying the Aggregation Bias in Sponsored Search Data" http://bit.ly/cKqRwl @WhartonInteract […]wharton (The Wharton School)
- New paper: "Identifying the Aggregation Bias in Sponsored Search Data" http://bit.ly/cKqRwl @WhartonInteract #fb September 10, 2010New paper: "Identifying the Aggregation Bias in Sponsored Search Data" http://bit.ly/cKqRwl @WhartonInteract #fb […]faderp (Peter Fader)
- RT @PrivacyLaw: Douwe Korff & Ian Brown, "New Challenges to Data Protection - Final Report " http://bit.ly/dhrlv5 September 10, 2010RT @PrivacyLaw: Douwe Korff & Ian Brown, "New Challenges to Data Protection - Final Report " http://bit.ly/dhrlv5 […]PrivacyDigest (PrivacyDigest)
- SSRN-What's Reasonable?: Self-Defense and Mistake in Criminal and ...: Self-Defense and Mistake in Criminal and To... http://bit.ly/cU4JMD September 10, 2010SSRN-What's Reasonable?: Self-Defense and Mistake in Criminal and ...: Self-Defense and Mistake in Criminal and To... http://bit.ly/cU4JMD […]legallawwatch (attorney law)
- NYT reports on China's WTO problems: http://ping.fm/tJ7aK But, green economy is raising trade issues in US too: http://ping.fm/Q2g5D September 10, 2010
SSRN Links
Tags
Aart Kraay A Quantitative Approach to Tactical Asset Allocation Asset allocation Brookings Institution Business Colleges and Universities Corporate Governance Daniel Kaufmann downloads Economic Economics Education eLibrary ERPN FEN Finance Gregg Gordon Harvard Business School Harvard Law School Harvard University Law Law school LSN Massimo Mastruzzi Mebane T. Faber Michael C. Jensen Nassim Nicholas Taleb National Bureau of Economic Research Otto Van Hemert Pablo Fernandez Recent Announcements Research Social Science Research Network Social sciences SSRN Links Stanford Graduate School of Business Stanford University Technology & Development Top Papers United States University of California University of Navarra William H. Meckling World Bank Institute Yuliya S. DemyanykCategories
Archives
Weekly Announcements – February 8, 2010
Here are the latest announcements from SSRN:
Announcing Lawyers, Drugs & Money: A Prescription for Antitrust Enforcement in the Pharmaceutical Industry on SSRN
In cooperation with The University of San Francisco School of Law and the Rutgers Law Journal, the Legal Scholarship Network (LSN) is pleased to announce the Lawyers, Drugs & Money: A Prescription for Antitrust Enforcement in the Pharmaceutical Industry Online Proceedings. These proceedings are available to all users at no charge and contain abstracts of the meeting’s papers with links to the full text within the SSRN eLibrary.
One of the most pressing issues of our time is how to encourage medical innovation while containing the costs of medication. Judges grapple with this challenge in litigation over patent rights and antitrust law. The result is a potent dose of lawyers, drugs and money, the topic of our symposium.
The University of San Francisco School of Law hosted a day-long symposium on Friday, September 25, 2009 in Fromm Hall. The symposium included five panels addressing cutting edge issues relevant to enforcement of the antitrust laws in the pharmaceutical industry. These panels considered topics such as reverse payments (or pay-for-delay settlements), product hopping, standing and preemption, burdens of proof, and class certification in antitrust cases.
You can browse all Lawyers, Drugs & Money: A Prescription for Antitrust Enforcement in the Pharmaceutical Industry Symposium abstracts in the SSRN database by clicking on the following link. The current drafts of the papers are available now and the final versions should be uploaded soon. You may wish to bookmark it in your browser.
View Papers: http://www.ssrn.com/link/Lawyers-Drugs-Money.html